Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Alx Oncology Holdings Inc (NQ: ALXO ) 7.380 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Jun 17, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 0 Open 7.380 Bid (Size) 7.380 (2) Ask (Size) 7.670 (1) Prev. Close 7.380 Today's Range 7.380 - 7.380 52wk Range 3.936 - 17.82 Shares Outstanding 40,869,135 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News ALX Oncology Presents First Evorpacept Combination Data with an Antibody-Drug Conjugate from Phase 1 ASPEN-07 Clinical Trial in Patients with Advanced Bladder Cancer June 02, 2024 From ALX Oncology Via GlobeNewswire ALX Oncology Announces Participation in the Jefferies Global Healthcare Conference May 29, 2024 From ALX Oncology Via GlobeNewswire Performance YTD -49.28% -49.28% 1 Month -46.48% -46.48% 3 Month -32.60% -32.60% 6 Month -45.70% -45.70% 1 Year -9.34% -9.34% More News Read More ALXO Stock Earnings: ALX Oncology Holdings Beats EPS for Q1 2024 May 09, 2024 Via InvestorPlace ALX Oncology Reports First Quarter 2024 Financial Results and Provides Corporate Update May 09, 2024 From ALX Oncology Via GlobeNewswire ALX Oncology Holdings Inc. (NASDAQ: ALXO) Leading the Way in Friday Trading Based on Percentage Gain December 08, 2023 Via Investor Brand Network ALX Oncology Appoints Allison Dillon as Chief Business Officer May 07, 2024 From ALX Oncology Via GlobeNewswire ALX Oncology Announces Initiation of Phase 2 Investigator-Sponsored Trial of Neoadjuvant Radiation and Evorpacept in Combination with Pembrolizumab in Patients with Untreated HPV-Mediated Oropharyngeal Cancer April 30, 2024 From ALX Oncology Via GlobeNewswire ALX Oncology Announces Two Evorpacept Abstracts Accepted for Poster Presentation at 2024 ASCO Annual Meeting April 24, 2024 From ALX Oncology Via GlobeNewswire Where ALX Oncology Holdings Stands With Analysts December 08, 2023 Via Benzinga The Latest Analyst Ratings for ALX Oncology Holdings November 14, 2023 Via Benzinga Why Travelers Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session April 17, 2024 Via Benzinga United Airlines Reports Upbeat Results, Joins Children's Place, Interactive Brokers And Other Big Stocks Moving Higher On Wednesday April 17, 2024 Via Benzinga Topics Stocks Exposures US Equities ALX Oncology Reports Encouraging Clinical Data of Evorpacept in Combination with Standard-of-Care in an Ongoing Phase 1/2 Clinical Trial in Patients with Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (“R/R B-NHL”) April 09, 2024 From ALX Oncology Via GlobeNewswire ALX Oncology Has 'Elevated Valuation' - Analyst Downgrades Stock, Highlights Need For Development De-Risking Beyond Gastric Cancer March 08, 2024 Via Benzinga 12 Health Care Stocks Moving In Friday's Pre-Market Session March 08, 2024 Via Benzinga ALXO Stock Earnings: ALX Oncology Holdings Beats EPS for Q4 2023 March 07, 2024 Via InvestorPlace ALX Oncology Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update March 07, 2024 From ALX Oncology Via GlobeNewswire ALX Oncology Announces Two Evorpacept Clinical Abstracts Accepted for Presentation at the AACR Annual Meeting March 05, 2024 From ALX Oncology Via GlobeNewswire ALX Oncology to Present at the 42nd Annual J.P. Morgan Healthcare Conference January 03, 2024 From ALX Oncology Via GlobeNewswire 7 Small-Cap Stocks That Wall Street Loves for Good Reason December 22, 2023 Via InvestorPlace Why AAR Shares Are Trading Lower By 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session December 22, 2023 Via Benzinga Karuna Therapeutics Jumps Following Takeover By Bristol Myers, Joins Rocket Lab USA, Altair Engineering And Other Big Stocks Moving Higher On Friday December 22, 2023 Via Benzinga Topics Stocks Exposures US Equities Why Comtech Telecommunications Shares Are Trading Lower By Over 16%? Here Are Other Stocks Moving In Friday's Mid-Day Session December 08, 2023 Via Benzinga 12 Health Care Stocks Moving In Friday's Intraday Session December 08, 2023 Via Benzinga Torrid Reports Upbeat Results, Joins MBIA, Virco Mfg. And Other Big Stocks Moving Higher On Friday December 08, 2023 Via Benzinga Topics Stocks Exposures US Equities Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
